Potency Testing of Venoms and Antivenoms in Embryonated Eggs: An Ethical Alternative to Animal Testing
Venoms are complex mixtures of biologically active molecules that impact multiple physiological systems. Manufacture of antivenoms (AVs) therefore requires potency testing using in vivo models to ensure AV efficacy. As part of ongoing research to replace small animals as the standard model for AV po...
Main Authors: | Erin E. Verity, Kathy Stewart, Kirsten Vandenberg, Chi Ong, Steven Rockman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/13/4/233 |
Similar Items
-
Proteomics, toxicity and antivenom neutralization of Sri Lankan and Indian Russell’s viper (Daboia russelii) venoms
by: Tasnim Faisal, et al.
Published: (2021-04-01) -
Preclinical efficacy testing of three antivenoms against Naja ashei venom-induced lethality
by: Mitchel Otieno Okumu, et al.
Published: (2022-06-01) -
Proteomics and antivenom immunoprofiling of Russell’s viper (Daboia siamensis) venoms from Thailand and Indonesia
by: Thava Malar Changra Lingam, et al.
Published: (2020-01-01) -
Biotechnological Trends in Spider and Scorpion Antivenom Development
by: Andreas Hougaard Laustsen, et al.
Published: (2016-07-01) -
Omics Meets Biology: Application to the Design and Preclinical Assessment of Antivenoms
by: Juan J. Calvete, et al.
Published: (2014-12-01)